DOJ’s New Whistleblower Program Increases Health Care Oversight

TL/DR –

The Department of Justice (DOJ) has commenced a new whistleblower program that facilitates enhanced scrutiny of the healthcare industry. This is expected to encourage employees to come forward with information regarding potential corporate wrongdoing, consequently enabling the DOJ to uncover more cases of healthcare fraud. However, critics argue this development poses a threat to internal investigations and may undermine privilege protection.

New DOJ Whistleblower Program Intensifies Health Care Industry Review

Manatt, Phelps & Phillips, LLP discusses the implications of the new DOJ Whistleblower Program on the health care industry.

Expert Insight: Liza P. Sawyer of Hall Render Killian Heath & Lyman PC

Liza P. Sawyer, a legal expert at Hall Render Killian Heath & Lyman PC, provides her professional viewpoint.

Encouraging Whistleblowing: The Role of HR

HR Brew provides insight on how human resources can motivate employees to come forward with information under the new DOJ Whistleblower Program.

Internal Probe Challenges: Whistleblower Pilot and Privilege Risk

Bloomberg Law highlights the potential pitfalls internal probes face due to the Whistleblower Pilot and privilege risk.

Former Chief of SEC Speaks Up

Arnold & Porter shares the perspective of the Former Chief of SEC on whistleblowing and corporate transparency.
—
Read More Health & Wellness News ; US News